ACG Releases New Idiosyncratic Drug-Induced Liver Injury Guidelines
The guidelines include an overview of risk factors, diagnostic tools, casualty assessment, prognosis factors and management of hepatotoxicity. DILI incidence is on the rise and the guidelines are designed to help physicians diagnose and manage the rare, difficult-to-diagnose adverse drug reaction.
The guidelines focus on herbal and dietary supplements due to the overall lack of regulation. Traces of heavy metals and prescription drugs have been found in some herbal and dietary supplements, according to guidelines co-author Herbert L. Bonkovsky, MD, FACG.
More Articles on Gastroenterology:
Can Independent GI Practices Survive & Thrive?
11 GI-Driven ASCs & Facilities Opened in 2014
Mayo Clinic Winds Award for Cologuard: 5 Things to Know
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- SourceMed, Change Healthcare partner on outpatient medical billing services: 5 key points
- Change Healthcare and SourceMed partner in order to create integrated billing solutions for outpatient providers
- 5 risks ASC owners face when they don't have a succession plan
- 5 things to know about AAAHC's Dr. Arnaldo Valedon
- Global capsule endoscopy market to grow at CAGR 14.8% until 2020: 5 trends